Results 101 to 110 of about 4,135 (194)

PDE10A mutations help to unwrap the neurobiology of hyperkinetic disorders [PDF]

open access: yes, 2019
The dual-specific cAMP/cGMP phosphodiesterase PDE10A is exclusively localised to regions of the brain and specific cell types that control crucial brain circuits and behaviours. The downside to this expression pattern is that PDE10A is also positioned to
Baillie, George S.   +3 more
core   +1 more source

Maternal Pre-Pregnancy Obesity Is Associated with Altered Placental Transcriptome [PDF]

open access: yes, 2018
Maternal obesity has a major impact on pregnancy outcomes. There is growing evidence that maternal obesity has a negative influence on placental development and function, thereby adversely influencing offspring programming and health outcomes.
Altmäe, Signe   +11 more
core   +1 more source

Initial clinical profile of the PDE10A inhibitor MK-8189 in people with an acute episode of schizophrenia

open access: gold, 2022
Yuki Mukai   +8 more
openalex   +1 more source

MODL-41. LOSS OF DISTAL CHROMOSOME 6Q AND ASSOCIATED PDE10A INDUCES AN AGGRESSIVE GLIOMA PHENOTYPE BY FACILITATING PRONEURAL TO MESENCHYMAL TRANSITION [PDF]

open access: green, 2023
Nicholas Nuechterlein   +19 more
openalex   +1 more source

Expression analysis of novel striatal-enriched genes in Huntington disease [PDF]

open access: yes, 2017
Selective degeneration of striatal neurons is a pathologic hallmark of Huntington disease (HD). The exact mechanism(s) behind this specific neurodegeneration is still unknown.
Becanovic, Kristina   +5 more
core  

Antidepressant treatment response is modulated by genetic and environmental factors and their interactions [PDF]

open access: yes, 2014
Although there is a wide variety of antidepressants with different mechanisms of action available, the efficacy of treatment is not satisfactory. Genetic factors are presumed to play a role in differences in medication response; however, available ...
Bagdy György   +6 more
core   +2 more sources

Design, synthesis, and behavioral evaluation of dual-acting compounds as phosphodiesterase type 10A (PDE10A) inhibitors and serotonin ligands targeting neuropsychiatric symptoms in dementia

open access: green, 2022
Agnieszka Zagórska   +10 more
openalex   +2 more sources

A loss-of-function homozygous mutation in DDX59 implicates a conserved DEAD-box RNA helicase in nervous system development and function. [PDF]

open access: yes, 2017
We report on a homozygous frameshift deletion in DDX59 (c.185del: p.Phe62fs*13) in a family presenting with orofaciodigital syndrome phenotype associated with a broad neurological involvement characterized by microcephaly, intellectual disability ...
Ashokkumar, B   +17 more
core   +1 more source

Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease

open access: yesNeurobiology of Disease, 2009
Decreased activity of cAMP responsive element-binding protein (CREB) is thought to contribute to the death of striatal medium spiny neurons in Huntington's disease (HD).
Carmela Giampà   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy